Lockjaw
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years (NCT01529645) | Novartis Vaccines | 2012-03-01 |
Track Lockjaw automatically
Every clearance here is in the API, with alerts when new ones post.